Dose Escalation and PK Study of M2ES in Subjects With Advanced Solid Tumors
Status:
Unknown status
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
This study is dose-escalation open-label study to determine the MTD of M2ES in Subjects With
Advanced Solid Tumors the recommended Phase II dose.The recommended dose and regimen of M2ES
will be selected to perform the pharmacokinetic study profiles.